Assertio Holdings (ASRT) Total Current Liabilities (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Total Current Liabilities came in at $91.6 million in Q1 2026, down 28.92% year-on-year from $128.8 million in Q1 2025, and down 28.19% quarter-over-quarter from $127.5 million in Q4 2025.
Assertio Holdings (ASRT) Total Current Liabilities (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Total Current Liabilities across 8 years of filings, most recently posting $91.6 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $91.6 million, down 28.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.6 million (down 28.92% YoY), and the FY2025 annual result was $127.5 million, up 11.18% from the prior year.
- Total Current Liabilities came in at $91.6 million for Q1 2026 at Assertio Holdings, down from $127.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $166.8 million in Q3 2025 to a low of $79.5 million in Q2 2023.
- The 5-year median for Total Current Liabilities is $95.3 million (2022), against an average of $109.5 million.
- Across the five-year window, Total Current Liabilities slumped 31.75% in 2023 and jumped 85.1% in 2025, its largest moves.
- Assertio Holdings' Total Current Liabilities stood at $95.3 million in 2022, then decreased by 1.97% to $93.4 million in 2023, then rose by 22.74% to $114.7 million in 2024, then grew by 11.18% to $127.5 million in 2025, then dropped by 28.19% to $91.6 million in 2026.
- The last three Total Current Liabilities figures came in at $91.6 million (Q1 2026), $127.5 million (Q4 2025), and $166.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 91.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.57 Mn |
| Dec 31, 2025 | 127.51 Mn |
| Sep 30, 2025 | 166.78 Mn |
| Jun 30, 2025 | 132.53 Mn |
| Mar 31, 2025 | 128.83 Mn |
| Dec 31, 2024 | 114.69 Mn |
| Sep 30, 2024 | 90.10 Mn |
| Jun 30, 2024 | 92.18 Mn |
| Mar 31, 2024 | 92.44 Mn |
| Dec 31, 2023 | 93.44 Mn |
| Sep 30, 2023 | 114.29 Mn |
| Jun 30, 2023 | 79.48 Mn |
| Mar 31, 2023 | 94.55 Mn |
| Dec 31, 2022 | 95.32 Mn |
| Sep 30, 2022 | 92.30 Mn |
| Jun 30, 2022 | 116.15 Mn |
| Mar 31, 2022 | 138.53 Mn |
| Dec 31, 2021 | 135.02 Mn |
| Sep 30, 2021 | 100.48 Mn |
| Jun 30, 2021 | 116.91 Mn |